New fragrance collection, designed with The Aroma Labs, captures vacation in a bottle
LANSING, Mich., June 20, 2025 /PRNewswire/ -- Beloved travel brand, Pure Michigan...
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
New late-breaking data at EAACI showed Dupixent outperformed Xolair across all primary and secondary efficacy endpoints of CRSwNP and in all asthma-related endpoints